Colgate-Palmolive Company (CL)
Official siteCONSUMER DEFENSIVE • HOUSEHOLD & PERSONAL PRODUCTS • NYSE
Market Cap: $79.23B
Last updated: Nov 17, 2026 at 11:05 AM ET
Colgate-Palmolive Company (CL) Earnings: Report Dates and Results
Colgate-Palmolive Company (CL) is expected to report earnings on Jan 28, 2027. In the quarter ended Sep 30, 2026, Colgate-Palmolive Company reported EPS of $0.97, above the $0.92 estimate. It beat the EPS estimate in each of the last 15 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
CL has an expected report date of Jan 28, 2027. Analysts' consensus for the quarter ending Dec 31, 2026 is 6.3% above the $0.95 reported for the quarter ended Dec 31, 2025.
CL Earnings Call
The latest CL earnings call transcript on file is labeled 2026Q3.
Read the 2026Q3 transcriptEarnings History
Of the 40 quarters below that had an estimate, CL beat 28, missed 1 and matched 11. Revenue for the quarter ended Sep 30, 2026 was $5.37B, up 4.7% from $5.13B a year earlier.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | $0.97 | $0.92 | $0.89 - $0.95 | +5.43% | Beat | +6.6% | 17 | 1 up, 1 down | Oct 30, 2026 | $5.37B |
| Jun 30, 2026 | $0.99 | $0.95 | $0.91 - $0.97 | +4.21% | Beat | +7.6% | 17 | 0 up, 1 down | Jul 31, 2026 | $5.36B |
| Mar 31, 2026 | $0.97 | $0.94 | $0.92 - $0.97 | +3.19% | Beat | +6.6% | 15 | 6 up, 5 down | May 1, 2026 | $5.32B |
| Dec 31, 2025 | $0.95 | $0.91 | $0.89 - $0.93 | +4.40% | Beat | +4.4% | 15 | 2 up, 3 down | Jan 30, 2026 | $5.23B |
| Sep 30, 2025 | $0.91 | $0.89 | $0.86 - $0.91 | +2.25% | Beat | 0.0% | 16 | 1 up, 13 down | Oct 31, 2025 | $5.13B |
| Jun 30, 2025 | $0.92 | $0.89 | $0.85 - $0.92 | +3.37% | Beat | +1.1% | 15 | 5 up, 2 down | Aug 1, 2025 | $5.11B |
| Mar 31, 2025 | $0.91 | $0.86 | $0.83 - $0.89 | +5.81% | Beat | +5.8% | 18 | 1 up, 15 down | Apr 25, 2025 | $4.91B |
| Dec 31, 2024 | $0.91 | $0.89 | $0.87 - $0.92 | +2.25% | Beat | +4.6% | 16 | 1 up, 9 down | Jan 31, 2025 | $4.95B |
| Sep 30, 2024 | $0.91 | $0.88 | $0.87 - $0.91 | +3.41% | Beat | +5.8% | 17 | 3 up, 0 down | Oct 25, 2024 | $5.03B |
| Jun 30, 2024 | $0.91 | $0.87 | $0.84 - $0.89 | +4.60% | Beat | +18.2% | 18 | 5 up, 2 down | Jul 26, 2024 | $5.06B |
| Mar 31, 2024 | $0.86 | $0.81 | $0.76 - $0.86 | +6.17% | Beat | +17.8% | 16 | 6 up, 0 down | Apr 26, 2024 | $5.07B |
| Dec 31, 2023 | $0.87 | $0.85 | $0.80 - $0.88 | +2.35% | Beat | +13.0% | 17 | 4 up, 0 down | Jan 26, 2024 | $4.95B |
| Sep 30, 2023 | $0.86 | $0.80 | $0.78 - $0.82 | +7.50% | Beat | +16.2% | 16 | 4 up, 1 down | Oct 27, 2023 | $4.92B |
| Jun 30, 2023 | $0.77 | $0.75 | N/A | +2.67% | Beat | +6.9% | 14 | 3 up, 0 down | Jul 28, 2023 | $4.82B |
| Mar 31, 2023 | $0.73 | $0.70 | $0.64 - $0.75 | +4.29% | Beat | -1.4% | 17 | 2 up, 0 down | Apr 28, 2023 | $4.77B |
| Dec 31, 2022 | $0.77 | $0.77 | $0.74 - $0.79 | 0.00% | In line | -2.5% | 18 | 5 up, 1 down | Jan 27, 2023 | $4.63B |
| Sep 30, 2022 | $0.74 | $0.73 | $0.69 - $0.76 | +1.37% | Beat | -8.6% | 17 | 2 up, 1 down | Oct 28, 2022 | $4.46B |
| Jun 30, 2022 | $0.72 | $0.71 | $0.68 - $0.73 | +1.41% | Beat | -10.0% | 17 | 4 up, 1 down | Jul 29, 2022 | $4.48B |
| Mar 31, 2022 | $0.74 | $0.75 | $0.70 - $0.78 | -1.33% | Miss | -7.5% | 18 | 0 up, 1 down | Apr 29, 2022 | $4.40B |
| Dec 31, 2021 | $0.79 | $0.79 | $0.74 - $0.83 | 0.00% | In line | +2.6% | 17 | 1 up, 1 down | Jan 28, 2022 | $4.40B |
| Sep 30, 2021 | $0.81 | $0.80 | $0.77 - $0.85 | +1.25% | Beat | +2.5% | 15 | 0 up, 0 down | Oct 29, 2021 | $4.41B |
| Jun 30, 2021 | $0.80 | $0.80 | $0.75 - $0.83 | 0.00% | In line | +8.1% | 17 | N/A | Jul 30, 2021 | $4.26B |
| Mar 31, 2021 | $0.80 | $0.79 | $0.75 - $0.82 | +1.27% | Beat | +6.7% | 17 | N/A | Apr 30, 2021 | $4.34B |
| Dec 31, 2020 | $0.77 | $0.76 | $0.74 - $0.79 | +1.32% | Beat | +5.5% | 18 | N/A | Jan 29, 2021 | $4.32B |
| Sep 30, 2020 | $0.79 | $0.70 | $0.67 - $0.72 | +12.86% | Beat | +11.3% | 16 | N/A | Oct 30, 2020 | $4.15B |
| Jun 30, 2020 | $0.74 | $0.69 | $0.64 - $0.75 | +7.25% | Beat | +2.8% | 17 | N/A | Jul 31, 2020 | $3.90B |
| Mar 31, 2020 | $0.75 | $0.73 | $0.68 - $0.82 | +2.74% | Beat | +11.9% | 15 | N/A | May 1, 2020 | $4.10B |
| Dec 31, 2019 | $0.73 | $0.73 | $0.71 - $0.76 | 0.00% | In line | -1.4% | 17 | N/A | Jan 31, 2020 | $4.01B |
| Sep 30, 2019 | $0.71 | $0.70 | $0.68 - $0.71 | +1.43% | Beat | -1.4% | 18 | N/A | Nov 1, 2019 | $3.93B |
| Jun 30, 2019 | $0.72 | $0.72 | $0.71 - $0.75 | 0.00% | In line | -6.5% | 18 | N/A | Jul 26, 2019 | $3.87B |
| Mar 31, 2019 | $0.67 | $0.66 | $0.63 - $0.69 | +1.52% | Beat | -9.5% | 19 | N/A | Apr 26, 2019 | $3.88B |
| Dec 31, 2018 | $0.74 | $0.73 | $0.72 - $0.75 | +1.37% | Beat | -1.3% | 18 | N/A | Jan 25, 2019 | $3.81B |
| Sep 30, 2018 | $0.72 | $0.72 | $0.70 - $0.74 | 0.00% | In line | -1.4% | 17 | N/A | Oct 26, 2018 | $3.85B |
| Jun 30, 2018 | $0.77 | $0.77 | $0.75 - $0.80 | 0.00% | In line | +6.9% | 17 | N/A | Jul 27, 2018 | $3.89B |
| Mar 31, 2018 | $0.74 | $0.73 | $0.70 - $0.74 | +1.37% | Beat | +10.4% | 16 | N/A | Apr 27, 2018 | $4.00B |
| Dec 31, 2017 | $0.75 | $0.75 | $0.72 - $0.77 | 0.00% | In line | 0.0% | 19 | N/A | Jan 26, 2018 | $3.89B |
| Sep 30, 2017 | $0.73 | $0.73 | $0.71 - $0.75 | 0.00% | In line | 0.0% | 17 | N/A | Oct 27, 2017 | $3.97B |
| Jun 30, 2017 | $0.72 | $0.72 | $0.70 - $0.74 | 0.00% | In line | +2.9% | 18 | N/A | Jul 21, 2017 | $3.83B |
| Mar 31, 2017 | $0.67 | $0.66 | N/A | +1.52% | Beat | +6.3% | N/A | N/A | Apr 28, 2017 | $3.76B |
| Dec 31, 2016 | $0.75 | $0.75 | N/A | 0.00% | In line | +2.7% | N/A | N/A | Jan 27, 2017 | $3.72B |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was $3.69, up 2.8% from the year before. It was $2.81 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | $3.69 | +2.8% |
| Dec 31, 2024 | $3.59 | +11.1% |
| Dec 31, 2023 | $3.23 | +8.8% |
| Dec 31, 2022 | $2.97 | -7.2% |
| Dec 31, 2021 | $3.20 | +4.9% |
| Dec 31, 2020 | $3.05 | +7.8% |
| Dec 31, 2019 | $2.83 | -4.7% |
| Dec 31, 2018 | $2.97 | +3.5% |
| Dec 31, 2017 | $2.87 | +2.1% |
| Dec 31, 2016 | $2.81 | N/A |
Earnings Calls
The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 10,000 words across 19 speakers.
| Call | Period ending | Words | Speakers | Transcript |
|---|---|---|---|---|
| 2026Q3 | Sep 30, 2026 | 9,990 | 19 | |
| 2026Q2 | Jun 30, 2026 | 9,233 | 21 | |
| 2026Q1 | Mar 31, 2026 | 6,075 | 15 | |
| 2025Q4 | Dec 31, 2025 | 7,299 | 19 | |
| 2025Q3 | Sep 30, 2025 | 8,012 | 20 | |
| 2025Q2 | Jun 30, 2025 | 6,681 | 17 | |
| 2025Q1 | Mar 31, 2025 | 10,423 | 20 | |
| 2024Q4 | Dec 31, 2024 | 9,998 | 21 |
2026Q3 Earnings Call
Opening remarks
Claire Ross Executive Vice President, Investor Relations Good morning, and welcome to our Third Quarter 2026 Earnings Release Conference Call. This is Claire Ross, Executive Vice President, Investor Relations. Today's conference call will include forward-looking statements. Actual results could differ materially from these statements. Forward-looking statements inherently involve risks and uncertainties and are made on the basis of our views and assumptions at this time. Please refer to the third quarter earnings press release and our most recent filings with the SEC, including our 2025 annual report on Form 10-K and our subsequent SEC filings, all available on our website, for a discussion of the factors that could cause actual results to differ materially from these statements. These remarks also include a discussion of non-GAAP financial measures, which exclude certain items from reported results, including those identified in tables four, six, seven, eight, and nine of the third quarter earnings press release. A full reconciliation to the corresponding GAAP financial measures and related definitions is included in the earnings press release. Joining me on the call this morning are Noel Wallace, Chairman, President, and Chief Executive Officer, and Stan Sutula, Chief Financial Officer. Noel will provide you with his thoughts on our results and our 2026 outlook. We will then open it up for Q&A.
Noel Wallace Chairman, President, and CEO Thanks, Claire, and good morning, everyone. A few thoughts. We are clearly pleased to have delivered another quarter of solid top- and bottom-line growth, particularly in the context of the continued global volatility we are seeing. Our strong results were broad-based, with organic sales growth in all four of our categories and four of our five divisions. We delivered solid gross margin expansion in a challenging cost environment. Base business EPS came in ahead of our expectations, even as we continue to increase our advertising. We are driving operating leverage through our productivity programs, including funding-the-growth and the Strategic Growth and Productivity Program, which drove lower costs. Our balance sheet and cash flow performance through the third quarter was also very strong, with free cash flow up 7%, and we have returned $2.2 billion to shareholders year-to-date. Our strong on-the-ground execution, coupled with our continued investment in our AI capabilities, helped drive our performance. As was the case last quarter, sales growth was led by emerging markets, which were up mid-single digits, driven by India, Brazil, and China. We also had strong contributions from our European markets, where science-based premium innovation and our omni-channel demand generation model have led to record market shares. Our Hill's business had a very strong quarter across both therapeutic and wellness businesses. We are pleased with our global momentum, but remain focused on executing our U.S. turnaround.
Frequently Asked Questions About CL
When is Colgate-Palmolive Company's next earnings date?
Colgate-Palmolive Company's next earnings report is expected for Jan 28, 2027.
Did CL beat earnings estimates last quarter?
Yes. Colgate-Palmolive Company reported EPS of $0.97 for the quarter ended Sep 30, 2026, above the $0.92 estimate, a 5.43% surprise.
What EPS do analysts expect from CL next quarter?
The consensus EPS estimate for Colgate-Palmolive Company for the quarter ending Dec 31, 2026 is $1.01 from 21 analysts, with estimates from $0.94 to $1.07.
How often does CL beat earnings estimates?
Colgate-Palmolive Company beat the EPS estimate in each of the last 15 quarters, with an average surprise of +4.13%.
CL pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors